Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, Amsterdam, Netherlands
Eva Kozanli
Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, Amsterdam, Netherlands
Jelle Koopsen
Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, Amsterdam, Netherlands
Harry Vennema
Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands
RIVM COVID-19 molecular epidemiology group
Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands
Karim Hajji
Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands
Annelies Kroneman
Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands
Ivo van Walle
Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands
Don Klinkenberg
Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands
Jacco Wallinga
Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands
Colin A Russell
Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, Amsterdam, Netherlands
Dirk Eggink
Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, Amsterdam, Netherlands; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands
Chantal Reusken
Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands
Background: Variants of concern (VOCs) of SARS-CoV-2 have caused resurging waves of infections worldwide. In the Netherlands, the Alpha, Beta, Gamma, and Delta VOCs circulated widely between September 2020 and August 2021. We sought to elucidate how various control measures, including targeted flight restrictions, had impacted the introduction and spread of these VOCs in the Netherlands. Methods: We performed phylogenetic analyses on 39,844 SARS-CoV-2 genomes collected under the Dutch national surveillance program. Results: We found that all four VOCs were introduced before targeted flight restrictions were imposed on countries where the VOCs first emerged. Importantly, foreign introductions, predominantly from other European countries, continued during these restrictions. After their respective introductions into the Netherlands, the Alpha and Delta VOCs largely circulated within more populous regions of the country with international connections before asymmetric bidirectional transmissions occurred with the rest of the country and the VOC became the dominant circulating lineage. Conclusions: Our findings show that flight restrictions had limited effectiveness in deterring VOC introductions due to the strength of regional land travel importation risks. As countries consider scaling down SARS-CoV-2 surveillance efforts in the post-crisis phase of the pandemic, our results highlight that robust surveillance in regions of early spread is important for providing timely information for variant detection and outbreak control. Funding: None.